pancreatic neuroendocrine tumor pNET
Conditions
Interventions
Sponsors
Academisch Medisch Centrum
Eligibility
Age
18 Years to 64 Years
Inclusion criteria
Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: - the patient is 18 years of older - the patient is primarily treated with a surgical resection for pNET - the patients is in the follow up program of the Academic Medical Center of Amsterdam (AMC) - the patients is able to understand the given information
Exclusion criteria
Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: - the patient is younger than 18 years - the patient is not in the follow up program of the AMC - the patient had metastatic disease at the time of the primary tumor - the patient is not able to give informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome is the outcome of the NETest of the patients in the three different groups. A NET score (0-100%) is obtained from algorithmic analyses of PCR data using MATLAB (R2011a, Mathworks, Natick, MA, USA) . A value >= 20% will be considered as a positive test. Scores randing from 0-20% = negative (no evidence of tumor disease activity: NET-negative). Scores ranging from 20-43% are considered *low activity* (NET-positive). Scores ranging from 44-100% are considered *high activity* (NET-positive). | — |
Countries
The Netherlands
Outcome results
None listed